Unipharma Co., Ltd.(TW:6621)
NT$12.15+-0.05 (+1.25%)
TW:6621
Unipharma Co., Ltd. Revenue
NT$12.15
At close:+-0.05 (+1.25%)
Unipharma Co., Ltd. (6621) Revenue
Unipharma Co., Ltd. Revenue
Unipharma Co., Ltd. had a revenue of 39.74M in the quarter ending Jun 30, 2026, with -9.93%. This bring the company's revenue in the last twelve months to 83.87M, Decreased 5.17%. In the fiscal year ending Dec 31, 2025, Unipharma Co., Ltd. had annual revenue of 88.44M with -5.36% growth.
- Revenue (ttm)
- 83.87M
- Revenue Growth
- -7.61%
- P/S Ratio
- 4.88
- Revenue/Employee
- TWD 2,601,294
- Employees
- 34
- Market Cap
- TWD 431.34M
Revenue Chart
Unipharma Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 88.44M | -5.01M | -5.36% |
| Dec 31, 2024 | 93.45M | -9.77M | -9.46% |
| Dec 31, 2023 | 103.22M | -24.89M | -19.43% |
| Dec 31, 2022 | 128.11M | 22.72M | 21.56% |
| Dec 31, 2021 | 105.39M | -33.25M | -23.98% |
| Dec 31, 2020 | 138.63M | -15.64M | -10.14% |
| Dec 31, 2019 | 154.28M | -7.47M | -4.62% |
| Dec 31, 2018 | 161.74M | -6.12M | -3.65% |
| Dec 31, 2017 | 167.87M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.